|
US6339066B1
(en)
|
1990-01-11 |
2002-01-15 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C
|
|
US6537973B1
(en)
|
1992-03-16 |
2003-03-25 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide inhibition of protein kinase C
|
|
US5985558A
(en)
|
1997-04-14 |
1999-11-16 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
|
|
US6312894B1
(en)
*
|
1995-04-03 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
|
|
US5801155A
(en)
*
|
1995-04-03 |
1998-09-01 |
Epoch Pharmaceuticals, Inc. |
Covalently linked oligonucleotide minor grove binder conjugates
|
|
US6143901A
(en)
*
|
1996-07-31 |
2000-11-07 |
Genesoft, Inc. |
Complex formation between dsDNA and pyrrole imidazole polyamides
|
|
US6090947A
(en)
*
|
1996-02-26 |
2000-07-18 |
California Institute Of Technology |
Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
|
|
US6555692B1
(en)
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
|
WO1998045284A1
(en)
|
1996-02-26 |
1998-10-15 |
California Institute Of Technology |
Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
|
|
CN1260006A
(zh)
|
1996-02-26 |
2000-07-12 |
加利福尼亚州技术学院 |
双链dna和杂环低聚物之间复合物的形成
|
|
US6635417B1
(en)
|
1996-07-31 |
2003-10-21 |
California Institute Of Technology |
Complex formation between DSDNA and oligomer of cyclic heterocycles
|
|
JP2001513759A
(ja)
|
1996-02-26 |
2001-09-04 |
カリフォルニア・インスティチュート・オブ・テクノロジー |
二本鎖ｄｎａの副溝において結合する改良されたポリアミド
|
|
US6506906B1
(en)
|
1996-02-26 |
2003-01-14 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
|
US20040266706A1
(en)
*
|
2002-11-05 |
2004-12-30 |
Muthiah Manoharan |
Cross-linked oligomeric compounds and their use in gene modulation
|
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
|
US7812149B2
(en)
|
1996-06-06 |
2010-10-12 |
Isis Pharmaceuticals, Inc. |
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
JP2002515057A
(ja)
*
|
1996-08-01 |
2002-05-21 |
カリフォルニア・インスティチュート・オブ・テクノロジー |
ポリアミドｄｎａ結合リガンドによる遺伝子発現の阻害
|
|
US6143877A
(en)
*
|
1997-04-30 |
2000-11-07 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids
|
|
US6312925B1
(en)
*
|
1997-05-08 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Methods and compositions to facilitate D-loop formation by oligonucleotides
|
|
US6262252B1
(en)
*
|
1997-05-19 |
2001-07-17 |
Mirus, Inc. |
Single-step method for labeling nucleic acids with mustard or aziridine labeling reagents
|
|
WO1999001579A1
(en)
|
1997-07-01 |
1999-01-14 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
|
US6133246A
(en)
*
|
1997-08-13 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
|
|
US6809193B2
(en)
|
1997-08-13 |
2004-10-26 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
|
|
US5877309A
(en)
|
1997-08-13 |
1999-03-02 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides against JNK
|
|
US6518017B1
(en)
*
|
1997-10-02 |
2003-02-11 |
Oasis Biosciences Incorporated |
Combinatorial antisense library
|
|
US20030165888A1
(en)
*
|
2001-07-18 |
2003-09-04 |
Brown Bob D. |
Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
|
|
US20060167239A1
(en)
*
|
1997-12-02 |
2006-07-27 |
Slattum Paul M |
Compounds and processes for single-pot attachment of a label to siRNA
|
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
|
US6949367B1
(en)
|
1998-04-03 |
2005-09-27 |
Epoch Pharmaceuticals, Inc. |
Modified oligonucleotides for mismatch discrimination
|
|
US7045610B2
(en)
*
|
1998-04-03 |
2006-05-16 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
|
US6127121A
(en)
*
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
|
US6683173B2
(en)
*
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
|
US6072046A
(en)
*
|
1998-08-26 |
2000-06-06 |
Epoch Pharmaceuticals, Inc. |
Diaziridinyl-aryl and bis-[di(chloroethyl)amino]-aryl oligonucleotide conjugates and reagents for making the same
|
|
US6432642B1
(en)
*
|
1999-01-15 |
2002-08-13 |
Pe Corporation (Ny) |
Binary probe and clamp composition and methods for a target hybridization detection
|
|
US6410231B1
(en)
*
|
1999-02-26 |
2002-06-25 |
Incyte Genomics, Inc. |
SNP detection
|
|
KR20020013519A
(ko)
*
|
1999-04-08 |
2002-02-20 |
추후제출 |
보편적 및/또는 축퇴성 염기를 포함하는 안티센스올리고뉴클레오티드
|
|
US6339147B1
(en)
|
1999-07-29 |
2002-01-15 |
Epoch Biosciences, Inc. |
Attachment of oligonucleotides to solid supports through Schiff base type linkages for capture and detection of nucleic acids
|
|
US6660845B1
(en)
*
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
|
US7205105B2
(en)
*
|
1999-12-08 |
2007-04-17 |
Epoch Biosciences, Inc. |
Real-time linear detection probes: sensitive 5′-minor groove binder-containing probes for PCR analysis
|
|
US20040081959A9
(en)
*
|
1999-12-08 |
2004-04-29 |
Epoch Biosciences, Inc. |
Fluorescent quenching detection reagents and methods
|
|
US6727356B1
(en)
|
1999-12-08 |
2004-04-27 |
Epoch Pharmaceuticals, Inc. |
Fluorescent quenching detection reagents and methods
|
|
EP1944310A3
(en)
|
2000-03-01 |
2008-08-06 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
|
EP1995330A1
(en)
|
2000-03-01 |
2008-11-26 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
|
US7078536B2
(en)
*
|
2001-03-14 |
2006-07-18 |
Genesoft Pharmaceuticals, Inc. |
Charged compounds comprising a nucleic acid binding moiety and uses therefor
|
|
ATE362940T1
(de)
*
|
2000-03-16 |
2007-06-15 |
Genesoft Inc |
Geladene verbindungen mit einer nukleinsäure- bindenden einheit sowie deren verwendungen
|
|
WO2001092579A2
(en)
*
|
2000-05-30 |
2001-12-06 |
Pe Corporation (Ny) |
Methods for detecting target nucleic acids using coupled ligation and amplification
|
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
|
US7238795B2
(en)
*
|
2000-08-03 |
2007-07-03 |
Roche Molecular Systems, Inc. |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
|
US6358679B1
(en)
*
|
2000-08-24 |
2002-03-19 |
Pe Corporation (Ny) |
Methods for external controls for nucleic acid amplification
|
|
ATE312841T1
(de)
|
2001-03-08 |
2005-12-15 |
Applera Corp |
Verfahren zum entschützen von oligonukleotide
|
|
US6774082B2
(en)
*
|
2001-05-11 |
2004-08-10 |
Ibc Advanced Technologies, Inc. |
Compositions for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
|
|
US20020177157A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Yuling Luo |
Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity
|
|
US6825228B2
(en)
|
2001-06-13 |
2004-11-30 |
Genesoft Pharmaceuticals, Inc. |
Benzothiophene compounds having antiinfective activity
|
|
US8569516B2
(en)
|
2001-09-07 |
2013-10-29 |
Elitech Holding B.V. |
Compounds and methods for fluorescent labeling
|
|
US6972339B2
(en)
*
|
2001-09-07 |
2005-12-06 |
Epoch Biosciences, Inc. |
Compounds and methods for fluorescent labeling
|
|
US6744502B2
(en)
*
|
2001-09-28 |
2004-06-01 |
Pe Corporation (Ny) |
Shaped illumination geometry and intensity using a diffractive optical element
|
|
US6818420B2
(en)
*
|
2002-02-27 |
2004-11-16 |
Biosource International, Inc. |
Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
|
|
AU2003213836A1
(en)
*
|
2002-03-11 |
2003-09-29 |
Epoch Biosciences, Inc. |
Negatively charged minor groove binders
|
|
CA2494139A1
(en)
|
2002-08-02 |
2004-02-12 |
Genesoft Pharmaceuticals, Inc. |
Biaryl compounds having anti-infective activity
|
|
US7153658B2
(en)
*
|
2002-09-19 |
2006-12-26 |
Applera Corporation |
Methods and compositions for detecting targets
|
|
EP1556325A4
(en)
*
|
2002-09-20 |
2007-09-19 |
Integrated Dna Tech Inc |
ANTHRAQUINONE-BASED FLUORESCENCE EXTINGUISHING DYES AND METHODS OF MAKING AND USING SAME
|
|
US20040235005A1
(en)
*
|
2002-10-23 |
2004-11-25 |
Ernest Friedlander |
Methods and composition for detecting targets
|
|
AU2003285958A1
(en)
*
|
2002-10-25 |
2004-05-25 |
Genesoft Pharmaceuticals, Inc. |
Anti-infective biaryl compounds
|
|
US8604183B2
(en)
|
2002-11-05 |
2013-12-10 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
|
|
AU2003287270A1
(en)
*
|
2002-11-14 |
2004-06-03 |
The Scripps Research Institute |
PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR Alpha4/PAXILLIN BINDING
|
|
WO2004046387A1
(en)
*
|
2002-11-15 |
2004-06-03 |
Sangamo Biosciences, Inc. |
Methods and compositions for analysis of regulatory sequences
|
|
US7129214B2
(en)
*
|
2002-12-10 |
2006-10-31 |
Oscient Pharmaceuticals Corporation |
Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
|
|
WO2005001129A2
(en)
*
|
2003-06-06 |
2005-01-06 |
Applera Corporation |
Mobility cassettes
|
|
US7348146B2
(en)
*
|
2003-10-02 |
2008-03-25 |
Epoch Biosciences, Inc. |
Single nucleotide polymorphism analysis of highly polymorphic target sequences
|
|
DK1687609T3
(en)
*
|
2003-10-28 |
2015-01-12 |
Epoch Biosciences Inc |
Fluorescent probes for DNA detection by hybridization with improved sensitivity and low background
|
|
US7439341B2
(en)
*
|
2003-11-14 |
2008-10-21 |
Integrated Dna Technologies, Inc. |
Fluorescence quenching azo dyes, their methods of preparation and use
|
|
US7667024B2
(en)
*
|
2003-11-19 |
2010-02-23 |
Allelogic Biosciences Corp. |
Oligonucleotides labeled with a plurality of fluorophores
|
|
US8569474B2
(en)
|
2004-03-09 |
2013-10-29 |
Isis Pharmaceuticals, Inc. |
Double stranded constructs comprising one or more short strands hybridized to a longer strand
|
|
GB0406015D0
(en)
*
|
2004-03-17 |
2004-04-21 |
Dynal Biotech Asa |
Improvements in magnetic polymer particles
|
|
EP1740711A2
(en)
*
|
2004-04-01 |
2007-01-10 |
Bio-Rad Laboratories, Inc. |
Quantitative amplification with a labeled probe and 3' to 5' exonuclease activity
|
|
ES2375406T3
(es)
|
2004-04-26 |
2012-02-29 |
Wako Pure Chemical Industries, Ltd. |
Sonda y cebador para la detección de bacilos tuberculosos, y procedimiento para la detección de bacilos tuberculosos humanos con el uso de los mismos.
|
|
EP2471924A1
(en)
|
2004-05-28 |
2012-07-04 |
Asuragen, INC. |
Methods and compositions involving microRNA
|
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
|
US20070054276A1
(en)
*
|
2004-08-12 |
2007-03-08 |
Sampson Jeffrey R |
Polynucleotide analysis and methods of using nanopores
|
|
CA2576381A1
(en)
|
2004-08-13 |
2006-02-23 |
Epoch Biosciences, Inc. |
Amplification methods
|
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
|
WO2006034387A1
(en)
|
2004-09-21 |
2006-03-30 |
Applera Corporation |
TWO-COLOR REAL-TIME/END-POINT QUANTITATION OF MICRORNAS (miRNAs)
|
|
US20060078894A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Winkler Matthew M |
Methods and compositions for analyzing nucleic acids
|
|
ES2534300T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
WO2006076650A2
(en)
*
|
2005-01-12 |
2006-07-20 |
Applera Corporation |
Compositions, methods, and kits for selective amplification of nucleic acids
|
|
DE602005018840D1
(de)
|
2005-04-14 |
2010-02-25 |
Applied Biosystems Llc |
3'-modifizierte oligonukleotide mit pseudoisocytosin-nukleobasenderivaten sowie deren anwendungen als primer oder sonden
|
|
CN101175852B
(zh)
|
2005-05-13 |
2013-02-13 |
和光纯药工业株式会社 |
堪萨斯分枝杆菌检测用的引物和探针、以及使用它们检测堪萨斯分枝杆菌的方法
|
|
WO2006127507A2
(en)
|
2005-05-20 |
2006-11-30 |
Integrated Dna Technologies, Inc. |
Compounds and methods for labeling oligonucleotides
|
|
US20070048758A1
(en)
*
|
2005-06-09 |
2007-03-01 |
Epoch Biosciences, Inc. |
Improved primer-based amplification methods
|
|
US20070087360A1
(en)
*
|
2005-06-20 |
2007-04-19 |
Boyd Victoria L |
Methods and compositions for detecting nucleotides
|
|
EP1943348B1
(en)
|
2005-10-03 |
2013-01-02 |
Life Technologies Corporation |
Compositions, methods, and kits for amplifying nucleic acids
|
|
JP5239853B2
(ja)
|
2006-03-13 |
2013-07-17 |
和光純薬工業株式会社 |
変異遺伝子の検出方法
|
|
US20080166712A1
(en)
*
|
2006-04-10 |
2008-07-10 |
Ryusuke Murayama |
Gene detection method
|
|
US8188256B2
(en)
|
2006-05-02 |
2012-05-29 |
Wako Pure Chemical Industries, Ltd. |
Primer and probe for detection of Mycobacterium intracellulare
|
|
EP2029726A4
(en)
*
|
2006-06-09 |
2010-07-28 |
Univ Miami |
ASSESSMENT OF CELL COMPOSITION AND FRACTIVITY AND USES THEREOF
|
|
US20090092967A1
(en)
*
|
2006-06-26 |
2009-04-09 |
Epoch Biosciences, Inc. |
Method for generating target nucleic acid sequences
|
|
EP2049688B1
(en)
|
2006-08-01 |
2018-01-24 |
Applied Biosystems, LLC |
Detection of analytes and nucleic acids
|
|
WO2008017081A1
(en)
|
2006-08-04 |
2008-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the modulation of jnk proteins
|
|
GB0619325D0
(en)
*
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
|
US20080131878A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Asuragen, Inc. |
Compositions and Methods for the Detection of Small RNA
|
|
US8133701B2
(en)
*
|
2006-12-05 |
2012-03-13 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
|
US7902345B2
(en)
*
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
|
WO2008073919A2
(en)
*
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-20 regulated genes and pathways as targets for therapeutic intervention
|
|
JPWO2008075520A1
(ja)
|
2006-12-18 |
2010-04-08 |
和光純薬工業株式会社 |
マイコバクテリウム・アビウム検出用プライマー及びプローブ、並びにこれを用いたマイコバクテリウム・アビウムの検出方法
|
|
US9938641B2
(en)
*
|
2006-12-18 |
2018-04-10 |
Fluidigm Corporation |
Selection of aptamers based on geometry
|
|
US20110091377A1
(en)
|
2007-05-11 |
2011-04-21 |
The Johns Hopkins University |
Biomarkers for melanoma
|
|
US8143006B2
(en)
*
|
2007-08-03 |
2012-03-27 |
Igor Kutyavin |
Accelerated cascade amplification (ACA) of nucleic acids comprising strand and sequence specific DNA nicking
|
|
US8071338B2
(en)
*
|
2007-08-08 |
2011-12-06 |
Roche Molecular Systems, Inc. |
Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity
|
|
WO2009032781A2
(en)
|
2007-08-29 |
2009-03-12 |
Sequenom, Inc. |
Methods and compositions for universal size-specific polymerase chain reaction
|
|
US8361714B2
(en)
|
2007-09-14 |
2013-01-29 |
Asuragen, Inc. |
Micrornas differentially expressed in cervical cancer and uses thereof
|
|
US20100280098A1
(en)
*
|
2007-10-05 |
2010-11-04 |
Juliano Rudolph L |
Receptor targeted oligonucleotides
|
|
WO2009052386A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Asuragen, Inc. |
Micrornas differentially expressed in lung diseases and uses thereof
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
WO2009099037A1
(ja)
|
2008-02-08 |
2009-08-13 |
Wako Pure Chemical Industries, Ltd. |
クラミドフィラ・キャビエ検出用プライマー及びプローブ、並びにこれを用いたクラミドフィラ・キャビエの検出方法
|
|
LT2757091T
(lt)
|
2008-04-01 |
2017-09-11 |
Biosearch Technologies, Inc. |
Stabilizuotos nukleorūgšties tamsūs kvenčerio-fluoroforo zondai
|
|
WO2009126726A1
(en)
*
|
2008-04-08 |
2009-10-15 |
Asuragen, Inc |
Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
|
|
US8575123B2
(en)
|
2008-04-11 |
2013-11-05 |
Tekmira Pharmaceuticals Corporation |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
CN102046788B
(zh)
|
2008-05-28 |
2013-07-10 |
和光纯药工业株式会社 |
胞内分枝杆菌检测用引物和探针、以及使用该引物和探针检测胞内分枝杆菌的方法
|
|
US8097412B2
(en)
*
|
2008-07-12 |
2012-01-17 |
Biodiagnostics, Inc. |
DNA-based test for detection of annual and intermediate ryegrass
|
|
US20110171649A1
(en)
*
|
2008-09-10 |
2011-07-14 |
Igor Kutyavin |
Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v
|
|
US20100076185A1
(en)
*
|
2008-09-22 |
2010-03-25 |
Nils Adey |
Selective Processing of Biological Material on a Microarray Substrate
|
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
EP3699172A3
(en)
|
2008-11-10 |
2020-11-18 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
|
US9534255B2
(en)
*
|
2008-12-17 |
2017-01-03 |
Life Technologies Corporation |
Methods, compositions, and kits for detecting allelic variants
|
|
US8975389B2
(en)
|
2009-03-02 |
2015-03-10 |
Alnylam Pharmaceuticals, Inc. |
Nucleic acid chemical modifications
|
|
CN102428191A
(zh)
*
|
2009-03-18 |
2012-04-25 |
塞昆纳姆股份有限公司 |
热稳定性内切核酸酶在产生报道分子中的应用
|
|
EP3249053A1
(en)
|
2009-03-27 |
2017-11-29 |
Life Technologies Corporation |
Methods, compositions, and kits for detecting allelic variants
|
|
KR20220038506A
(ko)
|
2009-06-10 |
2022-03-28 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
WO2011037802A2
(en)
|
2009-09-28 |
2011-03-31 |
Igor Kutyavin |
Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes
|
|
WO2011046972A2
(en)
*
|
2009-10-12 |
2011-04-21 |
Life Technologies Corporation |
Compositions and methods for suppressing primer interactions
|
|
ES2574625T3
(es)
*
|
2009-11-25 |
2016-06-21 |
Elitechgroup B.V. |
Antagonistas de miARN de oligonucleótido conjugado con aglutinante del surco menor (MGB)
|
|
CA3044884A1
(en)
|
2009-12-07 |
2011-06-16 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
|
US20130017223A1
(en)
|
2009-12-18 |
2013-01-17 |
The University Of British Columbia |
Methods and compositions for delivery of nucleic acids
|
|
WO2011087707A1
(en)
|
2009-12-22 |
2011-07-21 |
Elitech Holding B.V. |
Hypertheromostable endonuclease iv substrate probe
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
WO2011094580A2
(en)
|
2010-01-28 |
2011-08-04 |
Alnylam Pharmaceuticals, Inc. |
Chelated copper for use in the preparation of conjugated oligonucleotides
|
|
WO2011118496A1
(ja)
|
2010-03-23 |
2011-09-29 |
和光純薬工業株式会社 |
クラミジア・トラコマティス検出用プライマー及びプローブ、並びにこれを用いたクラミジア・トラコマティスの検出方法
|
|
WO2011120049A1
(en)
|
2010-03-26 |
2011-09-29 |
Integrated Dna Technologies, Inc. |
Methods for enhancing nucleic acid hybridization
|
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
|
US9506057B2
(en)
|
2010-03-26 |
2016-11-29 |
Integrated Dna Technologies, Inc. |
Modifications for antisense compounds
|
|
CN103119054B
(zh)
|
2010-03-26 |
2017-01-18 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
|
WO2011123621A2
(en)
|
2010-04-01 |
2011-10-06 |
Alnylam Pharmaceuticals Inc. |
2' and 5' modified monomers and oligonucleotides
|
|
AU2011243039B2
(en)
|
2010-04-16 |
2015-01-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Real time PCR assay for detection of bacterial respiratory pathogens
|
|
WO2011133876A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising acyclic and abasic nucleosides and analogs
|
|
WO2011133868A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
GB201007868D0
(en)
|
2010-05-11 |
2010-06-23 |
Enigma Diagnostics Ltd |
Sequence detection assay
|
|
US9309565B2
(en)
|
2010-05-14 |
2016-04-12 |
Life Technologies Corporation |
Karyotyping assay
|
|
DK2576577T3
(en)
|
2010-05-28 |
2015-04-20 |
Life Technologies Corp |
Synthesis of 2 ', 3'-dideoxynucleosides for automated DNA synthesis and PYROPHOSPHOROLYSIS ACTIVATED POLYMERIZATION
|
|
US8808683B2
(en)
|
2010-06-02 |
2014-08-19 |
Merck Patent Gmbh |
Genetically modified bacterium of the species Listeria monocytogenes
|
|
WO2011163121A1
(en)
|
2010-06-21 |
2011-12-29 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
|
CA2803391C
(en)
|
2010-06-22 |
2021-11-09 |
Neogenix Oncology, Inc. |
Npc1 antibodies that bind a muc5ac epitope
|
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
WO2012016188A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
CA2809457C
(en)
|
2010-09-07 |
2019-07-30 |
Integrated Dna Technologies, Inc. |
Modifications for antisense compounds
|
|
EP2622091B1
(en)
|
2010-09-23 |
2019-03-13 |
Precision Biologics, Inc. |
Colon and pancreas cancer peptidomimetics
|
|
US8992908B2
(en)
|
2010-11-23 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of oral mucositis
|
|
US9999673B2
(en)
|
2011-01-11 |
2018-06-19 |
Alnylam Pharmaceuticals, Inc. |
PEGylated lipids and their use for drug delivery
|
|
US20120208189A1
(en)
|
2011-01-14 |
2012-08-16 |
Life Technologies Corporation |
Methods for isolation, identification, and quantification of mirnas
|
|
US20120196294A1
(en)
|
2011-01-17 |
2012-08-02 |
Life Technologies Corporation |
Workflow for detection of ligands using nucleic acids
|
|
ES2611343T3
(es)
|
2011-03-23 |
2017-05-08 |
Elitech Holding B.V. |
Análogos de 3-alquinil pirazolopirimidina funcionalizada como bases universales y métodos de uso
|
|
US8969003B2
(en)
|
2011-03-23 |
2015-03-03 |
Elitech Holding B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
|
US20140170653A1
(en)
|
2011-04-15 |
2014-06-19 |
Life Technologies Corporation |
Chemical ligation
|
|
EP2714939B1
(en)
|
2011-05-24 |
2015-04-15 |
Elitech Holding B.V. |
Detection of methicillin-resistant staphylococcus aureus
|
|
US9067997B2
(en)
|
2011-05-25 |
2015-06-30 |
Innate Pharma Sa |
Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders
|
|
US9567628B2
(en)
|
2011-06-08 |
2017-02-14 |
Life Technologies Corporation |
Polymerization of nucleic acids using proteins having low isoelectric points
|
|
EP3461807B1
(en)
|
2011-06-08 |
2023-07-12 |
Life Technologies Corporation |
Design and development of novel detergents for use in pcr systems
|
|
US9528987B2
(en)
|
2011-06-23 |
2016-12-27 |
University Of Washington |
Reagent patterning in capillarity-based analyzers and associated systems and methods
|
|
WO2013016321A1
(en)
|
2011-07-26 |
2013-01-31 |
Elitech Holding B.V. |
Minor groove binder phosphoramidites and methods of use
|
|
US9644241B2
(en)
|
2011-09-13 |
2017-05-09 |
Interpace Diagnostics, Llc |
Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
|
|
JP6250543B2
(ja)
|
2011-09-27 |
2017-12-20 |
アルニラム・ファーマシューティカルズ・インコーポレーテッド |
ジ脂肪族置換ｐｅｇ化脂質
|
|
GB201119903D0
(en)
*
|
2011-11-17 |
2011-12-28 |
Univ Vilnius |
Nucleic acid production and sequence analysis
|
|
US8981318B1
(en)
|
2011-12-30 |
2015-03-17 |
Gene Capture, Inc. |
Multi-dimensional scanner for nano-second time scale signal detection
|
|
NZ728724A
(en)
|
2012-05-11 |
2018-03-23 |
Reset Therapeutics Inc |
Carbazole-containing sulfonamides as cryptochrome modulators
|
|
US9394574B2
(en)
|
2012-06-12 |
2016-07-19 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for detecting Legionella nucleic acids in a sample
|
|
US9951378B2
(en)
|
2012-06-14 |
2018-04-24 |
Life Technologies Corporation |
Compositions, methods and kits for real time polymerase chain reaction (PCR)
|
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
|
CN104619722B
(zh)
|
2012-06-22 |
2022-10-04 |
达特茅斯大学理事会 |
新型vista-ig构建体和vista-ig用于治疗自身免疫性、过敏性和炎性疾病的用途
|
|
CA2884704C
(en)
|
2012-09-07 |
2023-04-04 |
Randolph J. Noelle |
Vista modulators for diagnosis and treatment of cancer
|
|
MX2015004191A
(es)
|
2012-10-04 |
2016-04-04 |
Univ Leland Stanford Junior |
Metodos y reactivos para la deteccion, cuantificacion y serotipado de virus del dengue.
|
|
WO2014071315A1
(en)
|
2012-11-02 |
2014-05-08 |
Life Technologies Corporation |
Novel compositions, methods and kits for enhancing pcr specificity
|
|
EP3336104A1
(en)
|
2012-12-28 |
2018-06-20 |
Precision Biologics, Inc. |
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
|
|
CN105050720A
(zh)
|
2013-01-22 |
2015-11-11 |
华盛顿大学商业化中心 |
顺序递送流体体积和相关的设备、系统和方法
|
|
WO2014165210A2
(en)
|
2013-03-12 |
2014-10-09 |
Life Technologies Corporation |
Universal reporter-based genotyping methods and materials
|
|
WO2014164874A2
(en)
|
2013-03-13 |
2014-10-09 |
Becton, Dickinson And Company |
Methods and compositions for modulation of amplification efficiency
|
|
WO2014159063A1
(en)
|
2013-03-14 |
2014-10-02 |
Elitech Holding B.V. |
Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
|
|
CN105102635B
(zh)
|
2013-03-15 |
2020-09-25 |
生命技术公司 |
肺癌的分类和可行性指数
|
|
EP2978446B1
(en)
|
2013-03-27 |
2020-03-04 |
The General Hospital Corporation |
Anti-cd33 antibody for use in treating alzheimer's disease
|
|
WO2014165710A2
(en)
|
2013-04-05 |
2014-10-09 |
Life Technologies Corporation |
Gene fusions
|
|
ES2654631T3
(es)
|
2013-05-13 |
2018-02-14 |
Elitechgroup B.V. |
PCR digital en gotas con sondas cortas de ranura menor
|
|
CN105722996A
(zh)
|
2013-09-13 |
2016-06-29 |
生命科技公司 |
癌症的分类和可行性指数
|
|
EP3060686B1
(en)
|
2013-10-22 |
2018-08-01 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Compositions and methods for detection of influenza viruses
|
|
JP6742238B2
(ja)
|
2013-10-25 |
2020-08-19 |
ライフ テクノロジーズ コーポレーション |
Ｐｃｒシステムにおいて使用するための新規化合物及びその用途
|
|
EP3063290B1
(en)
|
2013-10-30 |
2018-11-21 |
Merck Patent GmbH |
Method for isolating microorganisms from a complex sample
|
|
US10273301B2
(en)
|
2013-12-24 |
2019-04-30 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
|
EP3107930A1
(en)
|
2014-02-21 |
2016-12-28 |
THE UNITED STATES OF AMERICA, represented by the S |
Hiv-2 nucleic acids and methods of detection
|
|
CN106414768B
(zh)
|
2014-03-27 |
2020-05-29 |
生命技术公司 |
与癌症相关的基因融合体和基因变异体
|
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
|
US20170044631A1
(en)
|
2014-04-14 |
2017-02-16 |
The Unite States of America, as represented by the Secretary, Dept. of Health and Human Services |
Methods for rapid detection and identification of viral nucleic acids
|
|
KR20170016915A
(ko)
|
2014-06-11 |
2017-02-14 |
마이크로닉스 인코포레이티드. |
핵산의 분석을 위한 통합 검정 대조군을 갖는 마이크로 유체 공학적 카트리지 및 장치
|
|
JP6997619B2
(ja)
|
2014-06-11 |
2022-01-17 |
キャシー・エイ・グリーン |
液性免疫の抑制または増進のための、ｖｉｓｔａアゴニスト及びｖｉｓｔａアンタゴニストの使用
|
|
US9212388B1
(en)
|
2014-06-30 |
2015-12-15 |
Life Technologies Corporation |
Direct quantitative PCR absent minor groove binders
|
|
EP3207156A1
(en)
|
2014-10-13 |
2017-08-23 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
|
MX2017007136A
(es)
|
2014-12-05 |
2017-12-04 |
Immunext Inc |
Identificacion de vsig8 como el receptor vista putativo y su uso para producir moduladores vista/vsig8.
|
|
EP3230468B1
(en)
|
2014-12-12 |
2020-09-16 |
ELITechGroup, Inc. |
Methods and kits for detecting antibiotic resistant bacteria
|
|
EP3230467A1
(en)
|
2014-12-12 |
2017-10-18 |
ELITechGroup B.V. |
Methods and compositions for detecting antibiotic resistant bacteria
|
|
US20170369872A1
(en)
|
2014-12-18 |
2017-12-28 |
Alnylam Pharmaceuticals, Inc. |
Reversir tm compounds
|
|
EP3722314A1
(en)
|
2015-06-24 |
2020-10-14 |
Janssen Pharmaceutica NV |
Anti-vista antibodies and fragments
|
|
CA3205381A1
(en)
|
2015-07-17 |
2017-01-26 |
Alnylam Pharmaceuticals, Inc. |
Multi-targeted single entity conjugates
|
|
US10899836B2
(en)
|
2016-02-12 |
2021-01-26 |
Janssen Pharmaceutica Nv |
Method of identifying anti-VISTA antibodies
|
|
PE20190115A1
(es)
|
2016-04-15 |
2019-01-16 |
Immunext Inc |
Anticuerpos vista antihumanos y su uso
|
|
WO2017200790A1
(en)
|
2016-05-20 |
2017-11-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Real-time reverse transcriptase-polymerase chain reaction assay with modified probe for the diagnosis of rabies viruses and other lyssaviruses
|
|
WO2017218938A1
(en)
|
2016-06-16 |
2017-12-21 |
Life Technologies Corporation |
Novel compositions, methods and kits for microorganism detection
|
|
WO2018005284A1
(en)
|
2016-06-27 |
2018-01-04 |
The United State Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for influenza a virus subtyping
|
|
EP3504342B1
(en)
|
2016-08-26 |
2026-05-20 |
Life Technologies Corporation |
NUCLEIC ACID EXTRACTION AND AMPLIFICATION CONTROLS AND ASSOCIATED METHODS OF USE
|
|
WO2018047148A1
(en)
|
2016-09-12 |
2018-03-15 |
Novartis Ag |
Compounds for the inhibition of mirna
|
|
US11248261B2
(en)
|
2017-03-08 |
2022-02-15 |
Etablissement Francais Du Sang |
RhD gene allele associated with a weak D phenotype and its uses
|
|
WO2018162986A2
(en)
|
2017-03-09 |
2018-09-13 |
Elitechgroup B.V. |
Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes
|
|
US10677728B2
(en)
|
2017-08-17 |
2020-06-09 |
Elitechgroup B.V. |
Duplex stabilizing fluorescence quenchers for nucleic acid probes
|
|
JP2021502825A
(ja)
|
2017-11-13 |
2021-02-04 |
ライフ テクノロジーズ コーポレイション |
尿路微生物検出のための組成物、方法、およびキット
|
|
US10724017B1
(en)
|
2017-12-06 |
2020-07-28 |
Cepheid |
Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
|
|
US10724083B1
(en)
|
2017-12-06 |
2020-07-28 |
Cepheid |
Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands
|
|
US10689629B1
(en)
|
2017-12-06 |
2020-06-23 |
Cepheid |
Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands
|
|
CA3098623A1
(en)
|
2018-05-07 |
2019-11-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
US11155713B2
(en)
|
2018-05-29 |
2021-10-26 |
Elitechgroup, Inc. |
Carborhodamine compounds and methods of preparation thereof
|
|
EP3837383A1
(en)
|
2018-08-16 |
2021-06-23 |
Life Technologies Corporation |
Reagents, mixtures, kits and methods for amplification of nucleic acids
|
|
CA3114396A1
(en)
|
2018-09-28 |
2020-04-02 |
Alnylam Pharmaceuticals, Inc. |
Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
|
|
JP7432610B2
(ja)
|
2018-10-01 |
2024-02-16 |
ジェン－プローブ・インコーポレーテッド |
水痘帯状疱疹ウイルスを増幅または検出するための組成物および方法
|
|
WO2020236600A1
(en)
|
2019-05-17 |
2020-11-26 |
Alnylam Pharmaceuticals, Inc. |
Oral delivery of oligonucleotides
|
|
KR102982955B1
(ko)
|
2019-10-28 |
2026-06-29 |
제론 코포레이션 |
3-팔미토일-아미도-1,2-프로판다이올 및 3-팔미토일-아미도-2-하이드록시-1-다이메톡시트라이페닐메틸에터-프로판의 결정질 고체 및 이의 제조 및 사용 방법
|
|
IL292328B2
(en)
*
|
2019-10-28 |
2025-10-01 |
Geron Corp |
Succinylate-converted 3-(amido fatty acid)-2-hydroxy-1-(protected hydroxy)-propane salts, amorphous solids and methods for their preparation
|
|
WO2021092371A2
(en)
|
2019-11-06 |
2021-05-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
EP4055165A1
(en)
|
2019-11-06 |
2022-09-14 |
Alnylam Pharmaceuticals, Inc. |
Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
|
|
CA3173545A1
(en)
|
2020-02-18 |
2021-08-26 |
Life Technologies Corporation |
Compositions, kits, and methods for detection of viral sequences
|
|
CA3174708A1
(en)
|
2020-03-04 |
2021-09-10 |
Verve Therapeutics, Inc. |
Compositions and methods for targeted rna delivery
|
|
EP4132951A4
(en)
|
2020-04-09 |
2025-06-11 |
Verve Therapeutics, Inc. |
CHEMICALLY MODIFIED GENE EDITING GUIDE RNAS WITH CAS12B
|
|
DE202021100985U1
(de)
|
2020-06-26 |
2021-06-18 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein |
Ein diagnostisches Assay-Kit und Mittel zum Nachweis von Coronavirus-Nukleinsäure
|
|
EP3929310A1
(en)
|
2020-06-26 |
2021-12-29 |
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. |
Methods and means for corona virus nucleic acid detection
|
|
US20230257745A1
(en)
|
2020-07-10 |
2023-08-17 |
Alnylam Pharmaceuticals, Inc. |
Circular siRNAs
|
|
CN116075597A
(zh)
|
2020-07-23 |
2023-05-05 |
生命技术公司 |
在生物测定中使用的能量转移染料缀合物
|
|
WO2022020731A2
(en)
|
2020-07-23 |
2022-01-27 |
Life Technologies Corporation |
Compositions, systems and methods for biological analysis involving energy transfer dye conjugates and analytes comprising the same
|
|
CN116368226A
(zh)
|
2020-09-04 |
2023-06-30 |
维乎医疗有限公司 |
用于加帽rna的组合物和方法
|
|
US20240336914A1
(en)
|
2020-12-31 |
2024-10-10 |
Alnylam Pharmaceuticals, Inc. |
2'-modified nucleoside based oligonucleotide prodrugs
|
|
US20240343746A1
(en)
|
2020-12-31 |
2024-10-17 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
|
EP4278002A2
(en)
|
2021-01-18 |
2023-11-22 |
Life Technologies Corporation |
Compositions, kits and methods for direct amplification from crude biological samples
|
|
US20240392394A1
(en)
|
2021-01-25 |
2024-11-28 |
Life Technologies Corporation |
Compositions, kits and methods for detection of viral variant sequences
|
|
US20250333806A1
(en)
|
2021-03-23 |
2025-10-30 |
Life Technologies Corporation |
Compositions, kits, and methods for variant-resistant detection of target viral sequences
|
|
EP4074839A1
(en)
|
2021-04-16 |
2022-10-19 |
Biotype GmbH |
Optimized oligonucleotide tx probe for a multiplexing analysis of nucleic acids and a multiplexing method
|
|
WO2023283403A2
(en)
|
2021-07-09 |
2023-01-12 |
Alnylam Pharmaceuticals, Inc. |
Bis-rnai compounds for cns delivery
|
|
IL309897A
(en)
|
2021-07-21 |
2024-03-01 |
Alnylam Pharmaceuticals Inc |
Target gene IRNA compositions associated with a metabolic disorder and methods of using them
|
|
WO2023004400A1
(en)
|
2021-07-21 |
2023-01-26 |
Life Technologies Corporation |
Dibenzoxanthene quenchers, uses, and methods of preparation
|
|
EP4381098A1
(en)
|
2021-08-02 |
2024-06-12 |
Life Technologies Corporation |
Compositions, kits, and methods for detection of nucleic acid sequence loads
|
|
EP4380576A4
(en)
|
2021-08-03 |
2026-04-29 |
Verve Therapeutics Inc |
RNA TARGETED COMPOSITIONS AND ADMINISTRATION METHODS
|
|
EP4416284A1
(en)
|
2021-10-15 |
2024-08-21 |
Alnylam Pharmaceuticals, Inc. |
Extra-hepatic delivery irna compositions and methods of use thereof
|
|
CN118414438A
(zh)
|
2021-10-20 |
2024-07-30 |
生命科技公司 |
使用内部定量标准物定量核酸序列的组合物、试剂盒和方法
|
|
EP4522742A2
(en)
|
2022-05-13 |
2025-03-19 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
CN114672482B
(zh)
*
|
2022-05-31 |
2022-08-30 |
上海百力格生物技术有限公司 |
核酸探针制备方法
|
|
KR20250028452A
(ko)
|
2022-06-29 |
2025-02-28 |
라이프 테크놀로지스 코포레이션 |
멀티플렉싱된 분석으로부터 분석물 검출을 위한 시스템 및 방법
|
|
CN119790162A
(zh)
|
2022-06-29 |
2025-04-08 |
生命科技公司 |
用于使用通道内复用检测核酸的组合物、试剂盒和方法
|
|
EP4547683A2
(en)
|
2022-06-30 |
2025-05-07 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
|
WO2024054925A1
(en)
|
2022-09-09 |
2024-03-14 |
Life Technologies Corporation |
Compositions, kits and methods for detection of viral variant sequences
|
|
JP2025532985A
(ja)
|
2022-09-30 |
2025-10-03 |
アルナイラム ファーマシューティカルズ， インコーポレイテッド |
修飾二本鎖ｒｎａ剤
|
|
EP4350002A1
(en)
|
2022-10-07 |
2024-04-10 |
Biotype GmbH |
Nachweis von molekularen analyten auf der grundlage massgeschneiderter sondenkonkurrenz
|
|
WO2024102839A1
(en)
|
2022-11-10 |
2024-05-16 |
Life Technologies Corporation |
Compositions, kits, and methods for detection of viral sequences
|
|
EP4646495A1
(en)
|
2023-01-02 |
2025-11-12 |
Life Technologies Corporation |
Compositions, kits and methods for detection of viral sequences
|
|
US20240254568A1
(en)
|
2023-01-27 |
2024-08-01 |
Life Technologies Corporation |
Compositions, kits, and methods for detecting sti pathogen sequences
|
|
IL322261A
(en)
|
2023-02-09 |
2025-09-01 |
Alnylam Pharmaceuticals Inc |
Reverser molecules and methods of using them
|
|
JP2026514045A
(ja)
|
2023-04-12 |
2026-05-01 |
アルナイラム ファーマシューティカルズ， インコーポレイテッド |
二本鎖ｒｎａ剤の肝外デリバリー
|
|
WO2024238385A2
(en)
|
2023-05-12 |
2024-11-21 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
CN121335987A
(zh)
|
2023-05-12 |
2026-01-13 |
生命科技股份有限公司 |
用于多重聚合酶链式反应过程和数据分析的系统和方法
|
|
DE102023124346A1
(de)
|
2023-09-09 |
2025-03-13 |
Biotype Gmbh |
Verfahren zur Detektion des Endometriumkarzinoms Subtyp CN hoch
|
|
WO2025064660A2
(en)
|
2023-09-21 |
2025-03-27 |
Alnylam Pharmaceuticals, Inc. |
Activin a receptor type 1c (acvr1c) irna compositions and methods of use thereof
|
|
EP4613876A1
(en)
|
2024-03-08 |
2025-09-10 |
Pxlence BV |
Nucleic acid quantification using universal detection probes
|